-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • SCWorx (NASDAQ:WORX) stock rose 47.8% to $3.96 during Tuesday's pre-market session.
  • Integra Lifesciences (NASDAQ:IART) shares increased by 31.97% to $17.75. The market value of their outstanding shares is at $1.0 billion.
  • Rapport Therapeutics (NASDAQ:RAPP) shares moved upwards by 23.25% to $35.25. The market value of their outstanding shares is at $1.3 billion.
  • MapLight Therapeutics (NASDAQ:MPLT) shares moved upwards by 17.87% to $9.43. The market value of their outstanding shares is at $444.6 million.
  • Scilex Holding (NASDAQ:SCLX) shares rose 13.54% to $2.92. The company's market cap stands at $18.0 million.
  • Icecure Medical (NASDAQ:ICCM) shares moved upwards by 10.18% to $1.19. The company's market cap stands at $3.7 million.

Losers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares decreased by 41.5% to $0.07 during Tuesday's pre-market session.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) shares declined by 10.62% to $0.67.
  • 4D Molecular Therapeutics (NASDAQ:FDMT) shares declined by 10.09% to $11.05. The market value of their outstanding shares is at $678.9 million.
  • Mobile-health Network (NASDAQ:MNDR) shares decreased by 8.52% to $0.86. The market value of their outstanding shares is at $1.1 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) shares fell 8.5% to $1.4. The market value of their outstanding shares is at $5.0 million.
  • Dr Reddy's Laboratories (NYSE:RDY) stock declined by 8.26% to $12.0. The market value of their outstanding shares is at $10.8 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending